GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Summary
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED is registered in India and entered in the “Companies Register (Ministry of Corporate Affairs)” under number L24239MH1924PLC001151. Its legal form is Public Limited Company (Ltd). According to GLEIF, its ultimate parent is GSK PLC (United Kingdom), which is also its direct parent. That group has 55 subsidiaries with LEIs in 16 countries, 2 of them in India. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 21 May 2019 and the record was last updated on 26 Jun 2026; the next renewal is due by 20 May 2027. GLEIF's ISIN mapping lists 1 ISIN for this LEI. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The ultimate-parent link rests on accounts for the period ending 30 Mar 2024, more than 24 months before this data release. The group may have changed since.
Company details
| Legal form | Public Limited Company (Ltd) |
|---|---|
| Register | Companies Register (Ministry of Corporate Affairs) · Register website |
| Registration number | L24239MH1924PLC001151 |
| Registration authority | Ministry of Corporate Affairs |
| Jurisdiction | India |
| Registered address | GSK HOUSE, DR ANNIE BESANT ROAD WORLI, 400030 MUMBAI, India |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 12 Nov 1924 |
| LEI | 3358002TNSC1U2DWNY52 |
| LEI status | active |
| LEI first issued | 21 May 2019 |
| LEI record last updated | 26 Jun 2026 |
| Next LEI renewal | 20 May 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | GSK PLC | GSK PLC |
| Accounting period | 31 Mar 2023 to 30 Mar 2024 | 31 Mar 2023 to 30 Mar 2024 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | fully corroborated | fully corroborated |
| Accounting standard | IFRS | IFRS |
| Relationship start | 5 Dec 1999 | 5 Dec 1999 |
| Recorded at GLEIF since | 12 May 2026 | 12 May 2026 |
| Last updated | 12 May 2026 | 12 May 2026 |
| Record status | current | current |
Direct subsidiaries (1)
- BIDDLE SAWYER LIMITED India · MUMBAI
Other subsidiaries of the same direct parent (34)
- 14245563 CANADA INC. Canada
- BELLUS HEALTH INC. Canada
- BURROUGHS WELLCOME INTERNATIONAL LIMITED United Kingdom lapsed
- CORIXA CORPORATION United States
- ESKAYLAB LIMITED United Kingdom lapsed
- GLAXO GROUP LIMITED United Kingdom
- GLAXO OPERATIONS UK LIMITED United Kingdom
- GLAXO WELLCOME PRODUCTION France
- GLAXO WELLCOME SA Spain
- GLAXO WELLCOME UK LIMITED United Kingdom
- GLAXOSMITHKLINE BIOLOGICALS France
- GLAXOSMITHKLINE BIOLOGICALS Belgium
ISINs mapped to this LEI (1)
US37734R1059
1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.